申请人:Ding Hongxia
公开号:US20130303544A1
公开(公告)日:2013-11-14
The present invention provides a kind of benzopyrone compounds having a structure of formula (I) and the pharmaceutically acceptable salts or prodrugs thereof, and the pharmaceutical compositions containing such compounds, which can be used to regulate the novel estrogen receptor ER-a36, and prevent and/or treat the related diseases mediated by the ER-a36 receptor, such as cancers, etc.
本发明提供了一种具有结构式(I)的苯并吡喃化合物及其药学上可接受的盐或前药,以及含有这种化合物的药物组合物,可用于调节新型雌激素受体ER-a36,并预防和/或治疗由ER-a36受体介导的相关疾病,如癌症等。